2018
DOI: 10.3389/fneur.2018.00497
|View full text |Cite
|
Sign up to set email alerts
|

Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage

Abstract: Background: Neuroprotection studies are generally unable to demonstrate efficacy in humans. Our specific hypothesis is that multiple pathophysiologic pathways, of variable importance, contribute to ischemic brain damage. As a corollary to this, we discuss the broad hypothesis that a multifaceted approach will improve the probability of efficacious neuroprotection. But to properly test this hypothesis the nature and importance of the multiple contributing pathways needs elucidation. Our aim is to demonstrate, u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 109 publications
0
4
0
Order By: Relevance
“…We performed a retrospective cohort study of 98 patients prospectively enrolled in an observational study on adult patients undergoing non-emergent cardiac surgery: deep hypothermic cardiac arrest aortic surgery or aortic valve replacement surgery. [ 20 ] The protocol was approved by the institutional biomedical review board and subjects provided written informed consent for the study including having their medical records used in research. Subjects with genotyping for the SNP, rs10830963, of MTNR1B were included.…”
Section: Methodsmentioning
confidence: 99%
“…We performed a retrospective cohort study of 98 patients prospectively enrolled in an observational study on adult patients undergoing non-emergent cardiac surgery: deep hypothermic cardiac arrest aortic surgery or aortic valve replacement surgery. [ 20 ] The protocol was approved by the institutional biomedical review board and subjects provided written informed consent for the study including having their medical records used in research. Subjects with genotyping for the SNP, rs10830963, of MTNR1B were included.…”
Section: Methodsmentioning
confidence: 99%
“…This requires reframing neuroprotection research. Neuroprotection based on functional genomics and utilizing a systems biology approach may ultimately provide improved outcomes for patients 22…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, nodes with higher ICSs are often informative with respect to reaction interplay and reversibility of the ability of DAMPs to induce cell injury 29 . The notion of multiple adverse protein pathways is important as it could potentially help to develop future targeted therapeutic strategies, enabling a multifaceted, individualized treatment approach for ABI 30,31 . Moreover, genetics studies have begun to identify individual differences in polymorphisms that could affect recovery and cognitive and social processing outcomes after traumatic brain injury 32 …”
Section: Discussionmentioning
confidence: 99%